8-K: Bio-Rad Co-Founder Alice Schwartz Passes Away at 99

Bio-Rad Laboratories, Inc. announced the passing of its co-founder and Director Emeritus, Alice N. Schwartz, at the age of 99.

Summary

• Alice N. Schwartz, co-founder and Director Emeritus of Bio-Rad Laboratories, Inc., passed away on September 25, 2025, at the age of 99.
• She co-founded Bio-Rad in 1952 in Berkeley, California, with her husband David Schwartz, shortly after graduating with a biochemistry degree from the University of California, Berkeley.
• Mrs. Schwartz was instrumental in developing Bio-Rad's first test kit for thyroid function in the 1960s, which marked the company's entry into clinical diagnostics.
• She remained an active Board member until 2022, and her leadership and passion for scientific discovery created a lasting legacy that continues to inspire the company and the broader scientific community.

Sentiment

Score: 5

Explanation: The announcement is a respectful and somber report of a co-founder's passing, carrying a neutral financial sentiment as it does not directly impact current operations or financial outlook.

Positives

• Alice Schwartz's instrumental role in co-founding Bio-Rad in 1952 and guiding its early growth.
• Her significant contribution to the development of the company's first thyroid function test kit, which initiated Bio-Rad's entry into clinical diagnostics.
• Her enduring legacy of leadership and passion for scientific discovery continues to inspire the company and the broader scientific community.

Negatives

• The passing of a foundational figure represents a loss of institutional memory and a direct link to the company's origins.

Future Outlook

The filing does not contain any forward-looking statements or guidance related to future financial performance or strategic direction.

Management Comments

• Alice N. Schwartz's leadership and passion for scientific discovery created a legacy that continues to inspire the company and the broader scientific community.

Industry Context

Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics products. Alice Schwartz's early contributions, particularly in developing the first thyroid function test kit, were foundational to the company's establishment in the clinical diagnostics field, a sector critical for healthcare and medical advancements.

Management Changes

Stakeholder Impact

• Shareholders: Symbolic impact from the loss of a foundational figure; no direct financial impact expected.
• Employees: Loss of an inspirational figure and a direct link to the company's founding values and history.
• Scientific Community: Acknowledgment of her contributions to life science research and clinical diagnostics.

Key Dates

Keywords

Bio-Rad, Alice Schwartz, Co-founder, Director Emeritus, Life Science, Clinical Diagnostics, Obituary, Corporate Governance